Aducanumab: A Deep Dive into BIIB037 and its Impact The drug, initially known as BIIB037, is a notable attempt to address emerging Alzheimer's illness. Created by Biogen, aducanumab acts by clearing amyloid deposits https://zaynabhlwd960627.pointblog.net/text-92500447